Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
40 results about "Microsporum lanosum" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Application of Scopariusins ??in preparation of antihuman fungal medicines
InactiveCN103479608AStrong inhibitory activityHighlight substantive featuresOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to an application of Scopariusins in the preparation of antihuman fungal medicines, and belongs to the medicinal field. Scopariusins has a very strong Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans inhibition effect, so the Scopariusins can be used as an antihuman fungal compound, and is expected to be applied in the preparation of related medicines. The skeleton type of the Scopariusins is a brand new skeleton type, and the Scopariusins has a strong human fungus inhibition activity, has prominent substantive characteristics, and is a substantial improvement in the prevention and treatment of human fungal infection.
Owner:SUZHOU CHENCAI TEXTILE RES & DEV
Application of Lycojaponicumin B in preparation of medicines for resisting human body fungi
InactiveCN103462989AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsLycojaponicumin BMicrosporum lanosum
The invention relates to an application of Lycojaponicumin B in the preparation of medicines for resisting human body fungi, belonging to the field of medicines. The Lycojaponicumin B has very strong inhibitory effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans. Therefore, the Lycojaponicumin B can serve as a compound capable of resisting human body fungi and is expected to be applied in the preparation of related medicines. The application of the Lycojaponicumin B in the preparation of the medicines for resisting human body fungi is disclosed for the first time. As the skeleton type of the Lycojaponicumin B belongs to a brand-new skeleton type, the Lycojaponicumin B has unexpected strong inhibitory activity on human body fungi, and the possibility that other compounds provide revelation does not exist. The Lycojaponicumin B has prominently substantial characteristics and meanwhile has remarkably progressive significance when being used for preventing and treating human body fungi infection.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH
Applications of Sarcaboside A in medicament against human fungus
InactiveCN103446115AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to applications of Sarcaboside A in preparing a medicament against human fungus, and belongs to the field of medicines. The Sarcaboside A plays a strong role in inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, the Sarcaboside A can serve as a compound with an anti-human fungus function, and is expected to be applied in preparing related medicaments. The applications of the Sarcaboside A in preparing the medicament against human fungus are disclosed for the first time. As a skeleton type of the Sarcaboside A belongs to a brand-new skeleton type, the Sarcaboside A has an unexpectedly strong human fungus inhibition activity, and the possibility of giving any inspiration by other compounds does not exist. The Sarcaboside A has significantly substantive characteristics, as well as obviously prominent progress in the prevention and treatment of the human fungus infection.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH
Application of Phyllanthoid A in preparing medicament for resisting human fungus
InactiveCN103463107AStrong inhibitory activityHighlight substantive featuresOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Phyllanthoid A in preparing a medicament for resisting human fungus, and belongs to the field of medicines. Phyllanthoid A has a strong effect in inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, thus can be used as a human fungus resistance compound, is expected to be applied to related medicaments, and is disclosed for the first time. The frame model belongs to a brand-new frame model, and Phyllanthoid A has a strong activity in inhibiting human body fungus, has a highlighted substantial characteristic, and is remarkably progressed in preventing and treating human fungus infection.
Owner:NANJING ZHENGLIANG MEDICAL TECH
Application of Scopariusins in preparation of antihuman fungal medicines
InactiveCN103479608BStrong inhibitory activityHighlight substantive featuresOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to an application of Scopariusins in the preparation of antihuman fungal medicines, and belongs to the medicinal field. Scopariusins has a very strong Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans inhibition effect, so the Scopariusins can be used as an antihuman fungal compound, and is expected to be applied in the preparation of related medicines. The skeleton type of the Scopariusins is a brand new skeleton type, and the Scopariusins has a strong human fungus inhibition activity, has prominent substantive characteristics, and is a substantial improvement in the prevention and treatment of human fungal infection.
Owner:SUZHOU CHENCAI TEXTILE RES & DEV
Application of Kanshone C to preparing drug for resisting human body fungi
InactiveCN105412063AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsDrugMicrosporum lanosum
The invention relates to application of Kanshone C to preparing drug for resisting human body fungi and belongs to the medicine field. Kanshone C has a high inhibition effect on red trichophyton, microsporum lanosum or fungi imperficti, and therefore Kanshone C can serve as compounds resisting human body fungi, and it is hopeful that Kanshone C is applied to preparing relevant drugs. The application of Kanshone C to preparing drug for resisting human body fungi is disclosed for the first time, due to the fact that the skeleton type is a brand-new skeleton type, Kanshone C has unexpected inhibition activity on human body fungi, it is not possible that other compounds provide any revelation, Kanshone C has outstanding substantive features, and remarkable progress is made in human body fungus infection prevention and treatment.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Application of Lycojaponicumin B in human fungus resisting medicine
ActiveCN103463029AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineLycojaponicumin B
The invention relates to an application of Lycojaponicumin B in preparation of a human fungus resisting medicine, belonging to the field of medicines. The Lycojaponicumin B has strong effects of inhibiting trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, therefore, the Lycojaponicumin B can be used as a compound with a human fungus resisting function, and is expected to be applied in the preparation of the related medicines. The application of the Lycojaponicumin B in preparation of the human fungus resisting medicine, disclosed by the invention, is disclosed for the first time. The skeleton type of the Lycojaponicumin B belongs to a brand-new skeleton type, and the human fungus inhibiting activity of the Lycojaponicumin B is unexpectedly strong, so that no possibility for providing any inspiration by other compounds exists. The Lycojaponicumin B has outstanding substantial characteristics, meanwhile, has a significant progress in prevention and treatment of human fungal infection.
Owner:王晓燕
Application of Racemulsonine in preparing medicine for resisting human body fungi
InactiveCN105412100AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Racemulsonine in preparing medicine for resisting human body fungi, and belongs to the field of medicine. Racemulsonine has the strong effect of inhibiting trichophyton rubrum or microsporum lanosum or trichophyton tonsurans, and thus Racemulsonine can serve as a compound for resisting human body fungi and is expected to be applied to preparing related medicine. The application is disclosed for the first time, Racemulsonine is in a bran-new skeleton type and has strong inhibitory activity on human body fungi, and thus Racemulsonine has outstanding substantive features. Meanwhile, Racemulsonine has remarkable progressiveness when used for preventing and treating human body fungus infection.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Application of Houttuynoid C in anti-human fungal drugs
InactiveCN102872145AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Houttuynoid C in preparing anti-human fungal drugs, belonging to the field of medicine. Houttuynoid C has strong effect of suppressing trichophyton rubrum, microsporum lanosum or trichophyton tonsurans; and therefore, Houttuynoid C can be taken as an anti-human fungal compound and is expected to be applied to preparing related drugs. The use of Houttuynoid C in preparing the anti-human fungal drugs involved in the invention is disclosed for the first time; as the framework type of Houttuynoid C is a brand new framework type and Houttuynoid C has an unexpectedly high inhibition activity for the human fungus without possibility of giving any implication by other compounds, Houttuynoid C has outstanding substantive features; and simultaneously, the application of Houttuynoid C for preventing and treating the human fungus apparently has obvious progress.
Owner:江苏鑫石器玄武岩纤维有限公司
Application of Houttuynoid E in anti-human fungal drugs
ActiveCN102872133BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to application of Houttuynoid E in preparing anti-human fungal drugs, belonging to the field of medicine. Houttuynoid E has strong effect of suppressing trichophyton rubrum, microsporum lanosum or trichophyton tonsurans; therefore, Houttuynoid E can be taken as an anti-human fungal compound and is expected to be applied to preparing related drugs. The use of Houttuynoid E inpreparing the anti-human fungal drugs involved in the invention is disclosed for the first time; as the framework type of Houttuynoid E is a brand new framework type and Houttuynoid E has an unexpectedly high inhibition activity for the human fungus without possibility of giving any implication by other compounds, Houttuynoid E has outstanding substantive features; and simultaneously, the application of Houttuynoid E for preventing and treating the human fungus apparently has obvious progress.
Owner:南通三聚知识产权服务有限公司
Application of Lycojaponicumin B in human fungus resisting medicine
ActiveCN103463029BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineLycojaponicumin B
The invention relates to an application of Lycojaponicumin B in preparation of a human fungus resisting medicine, belonging to the field of medicines. The Lycojaponicumin B has strong effects of inhibiting trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, therefore, the Lycojaponicumin B can be used as a compound with a human fungus resisting function, and is expected to be applied in the preparation of the related medicines. The application of the Lycojaponicumin B in preparation of the human fungus resisting medicine, disclosed by the invention, is disclosed for the first time. The skeleton type of the Lycojaponicumin B belongs to a brand-new skeleton type, and the human fungus inhibiting activity of the Lycojaponicumin B is unexpectedly strong, so that no possibility for providing any inspiration by other compounds exists. The Lycojaponicumin B has outstanding substantial characteristics, meanwhile, has a significant progress in prevention and treatment of human fungal infection.
Owner:王晓燕
Applications of compound in preparation anti human body fungus drugs
ActiveCN103393692AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumPharmacology
The invention relates to applications of Kadcoccitones A in preparation anti human body fungus drugs, and belongs to the field of medicine. Kadcoccitones A has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Kadcoccitones A can be taken as a compound with the function of anti human body fungi, and is advantageously used for corresponding drugs.
Owner:深圳市茵诺圣生物科技有限公司
Application of Gypensapogenin A in medicine for preventing human fungi
ActiveCN102861027BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumPharmacology
The invention discloses application of Gypensapogenin A in preparing a medicine for preventing human fungi, belonging to the medicine field. Gypensapogenin a has strong inhibiting functions on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Gypensapogenin A can be used as a compound for resisting human fungi, and can be applied for preparing relative medicine. The application of Gypensapogenin A in preparing the medicine for preventing human fungi, which is provided by the invention, is disclosed for the first time. The skeleton type belongs to brand-new skeleton type, and the human fungus inhibiting activity of Gypensapogenin A is extremely strong, so that no possibility for providing any prompt by other compounds exists. Gypensapogenin A has outstanding actual characteristics. Meanwhile, Gypensapogenin A has outstanding progress when being used for preventing and treating human fungus infection.
Owner:启东市天汾电动工具技术创新中心
Application of Houttuynoid D in anti-human fungi medicine
InactiveCN102861087BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Houttuynoid D in preparation of an anti-human fungi medicine, belonging to the technical field of new application of medicine. Houttuynoid D has very strong effect on inhibiting epidrmophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Houttuynoid D is taken as an anti-human fungi compound and is expected to be applied to preparation of the relative medicines. The application of Houttuynoid D in the anti-human fungi medicine is disclosed firstly. The skeleton type belongs to new skeleton type, and the activity of Houttuynoid D on inhibition of human fungi is unexpectedly strong; and the probability that any revelation is provided by other compounds does not exist, Houttuynoid D has the excellent substantive features, and Houttuynoid D obviously has a remarkable progress when being used for preventing and treating human fungi infection.
Owner:JIANGSU KANGHENG CHEM
Application of compound in preparation of antifungal drug for human body
ActiveCN103393692BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsAnti fungalMicrosporum lanosum
The invention relates to applications of Kadcoccitones A in preparation anti human body fungus drugs, and belongs to the field of medicine. Kadcoccitones A has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Kadcoccitones A can be taken as a compound with the function of anti human body fungi, and is advantageously used for corresponding drugs.
Owner:深圳市茵诺圣生物科技有限公司
Application of lycojaponicumin A in the preparation of anti-fungal drugs for human body
ActiveCN103446135BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
Owner:FENGJIE DONGYANG BUILDING MATERIALS CO LTD
Application of Aphanamixoid A for preparing human fungal resistant medicine
InactiveCN102988345AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to application of Aphanamixoid A for preparing a human fungal resistant medicine, belonging to the field of medicines. Aphanamixoid A has strong effects on inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, Aphanamixoid A can be used as a human fungal resistant compound and is hopeful to be used for preparing related medicines. The application of Aphanamixoid A for preparing the human fungal resistant medicine is disclosed for the first time; because the skeleton type belongs to a brand new skeleton type and the human fungal inhibitory activity of Aphanamixoid A is strong unexpectedly, the possibility that other compounds give any inspiration does not exist; Aphanamixoid A has outstanding substantive characteristics; and simultaneously, Aphanamixoid A has obvious progress for preventing and treating human fungal infection.
Owner:何晓涛
Application of Chukrasone B in preparation of medicines for resisting human body fungi
ActiveCN103372004AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to an application of Chukrasone B in the preparation of medicines for resisting human body fungi, and belongs to the field of medicines. The Chukrasone B has a very strong inhibition effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, the Chukrasone B can serve as a compound capable of resisting human body fungi and is expected to be applied in the preparation of related medicines. The application of the Chukrasone B in the preparation of the medicines for resisting the human body fungi is disclosed by the invention for the first time. As the skeleton type of the Chukrasone B belongs to a bran-new skeleton type and the Chukrasone B has unexpected strong inhibitory activity on human body fungi, the possibility that other compounds provide revelation does not exist. The Chukrasone B has prominently substantial characteristics and meanwhile has remarkably progressive significance when being used for preventing and treating the human body fungi infection.
Owner:煌途医药(无锡)有限公司
Application of Houttuynoid B in anti-human fungi medicine
ActiveCN102861083BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Houttuynoid B in preparation of an anti-human fungi medicine, belonging to the technical field of new application of medicine. Houttuynoid B has very strong effect on inhibition of epidrmophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Houttuynoid B is taken as an anti-human fungi compound and is expected to be applied to the preparation of the relative medicines. The application of Houttuynoid B in preparation of the anti-human fungi medicine provided by the invention is disclosed firstly. The skeleton type belongs to new skeletontype, and the activity of Houttuynoid B on inhibition of human fungi is unexpectedly strong; and the probability that any revelation is provided by other compounds does not exist, Houttuynoid B has the excellent substantive features, and Houttuynoid B obviously has a remarkable progress when being used for preventing and treating human fungi infection.
Owner:刘骏
Application of Chukrasone A for preparing antifungal drugs for human body
InactiveCN103393696AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsAntifungal drugChemical compound
The invention relates to an application of Chukrasone A for preparing antifungal drugs for a human body. Chukrasone A has strong inhibition effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so the Chukrasone A can be used as an anti human body fungal compound, and can be applied for preparing relative medicament. The application of Chukrasone A for preparing antifungal drugs for human body is firstly disclosed. Because a matrix type belongs to a new matrix type, and Chukrasone A has unexpectedly strong inhibition activity on human body fungus without possibility of any enlightenment given by other compounds, Chukrasone A has significantly substantive characteristics, and simultaneously has substantial progress for preventing human body infection fungus.
Owner:JIANGSU KEHUA MEDICAL INSTR TECH CO LTD
Applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies
InactiveCN105534989AStrong inhibitory activitySignificant progressAntimycoticsHeterocyclic compound active ingredientsAnti fungalMicrosporum lanosum
The invention relates to applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies and belongs to the field of medicines. The Trigonoliimines C has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore the Trigonoliimines C can be adopted as an anti-fungal compound for human bodies and is expected to be applied in preparation of related medicines.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Application of Houttuynoid A in anti-human fungus drugs
InactiveCN102895250AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to an application of Houttuynoid A in preparing anti-human fungus drugs and belongs to the field of medicines. The Houttuynoid A is very powerful in effect of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore, the Houttuynoid A can serve as an anti-human fungus compound, and is expected to be applied in preparing related drugs. The application of the Houttuynoid A in preparing the anti-human fungus drugs is disclosed for the first time. As the skeleton type of the Houttuynoid A is fire-new, and the inhibitory activity of the Houttuynoid A on human fungi is unexpectedly strong, the possibility that any enlightenments are given by other compounds does not exist. The Houttuynoid A is outstanding in substantive feature, and meanwhile, apparently makes a significant progress when being used for preventing and curing human fungus infections.
Owner:NANJING UNIV
Application of Gypensapogenin A in medicine for preventing human fungi
ActiveCN102861027AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumPharmacology
The invention discloses application of Gypensapogenin A in preparing a medicine for preventing human fungi, belonging to the medicine field. Gypensapogenin a has strong inhibiting functions on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Gypensapogenin A can be used as a compound for resisting human fungi, and can be applied for preparing relative medicine. The application of Gypensapogenin A in preparing the medicine for preventing human fungi, which is provided by the invention, is disclosed for the first time. The skeleton type belongs to brand-new skeleton type, and the human fungus inhibiting activity of Gypensapogenin A is extremely strong, so that no possibility for providing any prompt by other compounds exists. Gypensapogenin A has outstanding actual characteristics. Meanwhile, Gypensapogenin A has outstanding progress when being used for preventing and treating human fungus infection.
Owner:启东市天汾电动工具技术创新中心
Application of Incarviatone A in anti-human fungus drug
InactiveCN103446095AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to application of Incarviatone A in preparation of an anti-human fungus drug and belongs to the field of medicine. The Incarviatone A has good inhabiting effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that the Incarviatone A can serve as an anti-human fungus compound and is hopefully applied in preparation of related drugs. The application of the Incarviatone A in the preparation of the anti-human fungus drug is disclosed for the first time. Due to the fact that the skeleton type is a novel skeleton type and the high human fungus inhibitory activity Incarviatone A is previously unimagined, the possibility that other compounds give any revelation does not exist, and the Incarviatone A has outstanding substantive characteristics and meanwhile has a remarkable improvement in prevention and treatment of human fungus obviously.
Owner:NANJING GUANGKANGXIE BIOLOGICAL MEDICAL TECH
Application of Ternatusine A in preparation of human fungus resistant drugs
InactiveCN106474114AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to application of Ternatusine A in the preparation of human fungus resistant drugs and belongs to the field of medicine. Ternatusine A has great action for inhibiting Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, and therefore, Ternatusine A may act as human fungus resistant compounds and is expectedly applicable to the preparation of related drugs.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Application of Friedolanostanes in preparation of antihuman fungal medicines
InactiveCN106491620AStrong inhibitory activityHighlight substantive featuresOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to an application of Friedolanostanes in the preparation of antihuman fungal medicines, and belongs to the field of medicines. The Friedolanostanes have a very strong inhibition effect on Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, so the Friedolanostanes can be used as an antihuman fungal compound, and are hopeful to be applied to preparation of relevant medicines for the first time. The skeleton type of the Friedolanostanes is a brand new skeleton type, and the Friedolanostanes have high human fungus inhibition activity, have protruding practical characteristics, and have substantial progress in prevention and treatment of human fungus infection.
Owner:ZIBO DINGLI PATENT INFORMATION CONSULTING CO LTD
Application of Houttuynoid C in anti-human fungal drugs
InactiveCN102872145BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Houttuynoid C in preparing anti-human fungal drugs, belonging to the field of medicine. Houttuynoid C has strong effect of suppressing trichophyton rubrum, microsporum lanosum or trichophyton tonsurans; and therefore, Houttuynoid C can be taken as an anti-human fungal compound and is expected to be applied to preparing related drugs. The use of Houttuynoid C in preparing the anti-human fungal drugs involved in the invention is disclosed for the first time; as the framework type of Houttuynoid C is a brand new framework type and Houttuynoid C has an unexpectedly high inhibition activity for the human fungus without possibility of giving any implication by other compounds, Houttuynoid C has outstanding substantive features; and simultaneously, the application of Houttuynoid C for preventing and treating the human fungus apparently has obvious progress.
Owner:江苏鑫石器新材料有限公司
Application of Gypensapogenin B to preparing drugs for resisting human funguses
ActiveCN102872059BStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMicrosporum lanosumTrichophyton infection
The invention relates to application of Gypensapogenin B to preparing drugs for resisting human funguses, belonging to the field of medicines. Gypensapogenin B has very strong effect on inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, therefore, Gypensapogenin B can serve as a compound capable of resisting the human funguses and is expected to be applied to preparingrelated drugs. The application of Gypensapogenin B to preparing the drugs for resisting the human funguses, disclosed by the invention, is firstly published, the framework type is brand new, the activity of inhibiting the human funguses is unexpectedly strong and the probability of giving any revelation by other compounds does not exist, so that prominent substantive features are provided and a remarkable progress in preventing and treating the human fungus infection is made at the same time.
Owner:南通三聚知识产权服务有限公司
Application of polyflavanostilbene A in preparation of anti-human fungus medicine
InactiveCN103301142AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to an application of polyflavanostilbene A in the preparation of an anti-human fungus medicine, and belongs to the field of medicines. The polyflavanostilbene A has very strong effects on inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore the polyflavanostilbene A can be used as an anti-human fungus compound, and is hopefully to be applied to the preparation of relevant medicines. The invention discloses the application of the polyflavanostilbene A in the preparation of the anti-human fungus medicine for the first time; as the skeleton type is a brand-new skeleton type and the inhibition activity of the polyflavanostilbene A on human fungi is unexpectedly strong, the possibility of being inspired by other compounds is eliminated, and the polyflavanostilbene A has substantive distinguishing features; and the application of the polyflavanostilbene A in the prevention and treatment of human fungus infection is a significant progress.
Owner:NANJING ZHENGLIANG MEDICAL TECH
Application of Houttuynoid D in anti-human fungi medicine
InactiveCN102861087AStrong inhibitory activitySignificant progressOrganic active ingredientsAntimycoticsMedicineMicrosporum lanosum
The invention relates to application of Houttuynoid D in preparation of an anti-human fungi medicine, belonging to the technical field of new application of medicine. Houttuynoid D has very strong effect on inhibiting epidrmophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Houttuynoid D is taken as an anti-human fungi compound and is expected to be applied to preparation of the relative medicines. The application of Houttuynoid D in the anti-human fungi medicine is disclosed firstly. The skeleton type belongs to new skeleton type, and the activity of Houttuynoid D on inhibition of human fungi is unexpectedly strong; and the probability that any revelation is provided by other compounds does not exist, Houttuynoid D has the excellent substantive features, and Houttuynoid D obviously has a remarkable progress when being used for preventing and treating human fungi infection.
Owner:JIANGSU KANGHENG CHEM
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com